Trademark Details For LIGAPLEX (Serial Number 74714051)

  •  Home
  •  Print
LIGAPLEX
13
17
9
0
Serial Number  United States - USPTO 74714051
Registration Number 1984258
Mark
LIGAPLEX
Filing Date Aug-10-1995
Status
Registered  
REGISTERED A.. (800)
REGISTERED AND RENEWED
Attorney Name
TTAB
0




005Pharmaceuticals

U.S Class(es): 006, 018, 044, 046, 051, 052

Class Status: Active

First Use: 1965

First Use in Commerce: 1965





Correspondences

NameMelinda S. Giftos Husch Blackwell LLP
Address33 East Main Street, Suite 300 Madison, WI 53703 United States

Prosecution History

DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Jan-30-1996ASSIGNED TO EXAMINER   DOCKD
Feb-05-1996APPROVED FOR PUB - PRINCIPAL REGISTER   CNSAO
Mar-08-1996NOTICE OF PUBLICATION   NPUBO
Apr-09-1996PUBLISHED FOR OPPOSITION   PUBOA
Jul-02-1996REGISTERED-PRINCIPAL REGISTER   R.PRA
Apr-18-2002PAPER RECEIVED   MAILI
Apr-18-2002REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED   815FI
Jun-14-2002REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.   C15AO
Nov-18-2003TEAS CHANGE OF CORRESPONDENCE RECEIVED   TCCAI
Jun-09-2006TEAS SECTION 8 & 9 RECEIVED   E89RI
Jun-09-2006REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED   89AFI
Sep-10-2006ASSIGNED TO PARALEGAL   PLGLA
Sep-10-2006REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED   89AGO
Sep-10-2006REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)   RNL1Q
Jun-12-2007CASE FILE IN TICRS   CFITO
Jun-20-2016TEAS SECTION 8 & 9 RECEIVED   E89RI
Sep-09-2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL   APREA
Sep-09-2016REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED   89AGO
Sep-09-2016REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)   RNL2Q
Sep-09-2016NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED   NA89E
Mar-30-2020NOTICE OF SUIT   NOSUI
Jan-28-2021NOTICE OF SUIT   NOSUI
Jul-22-2021NOTICE OF SUIT   NOSUI
Oct-21-2021NOTICE OF SUIT   NOSUI
Jul-02-2025COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED   REM2E
Dec-15-2025TEAS SECTION 8 & 9 RECEIVED   E89RI